The EU has introduced a time-limited ‘transparency and authorization’ mechanism on exports of COVID-19 vaccines covered by the EU’s Advanced Purchase Agreements worth EUR 2.9 Billion,...
EMA has recommended granting a conditional marketing authorisation for COVID-19 Vaccine AstraZeneca to prevent coronavirus disease 2019 (COVID-19) in people from 18 years of age, including...
Following AstraZeneca's statement (22 January) that it would not be able to meet its delivery schedule agreed with the EU for its COVID-19 vaccine, Health Commissioner...
In response to AstraZeneca’s announcement that they were expecting to make shortfalls in the delivery of its COVID-19 vaccine, Health Commissioner Stella Kyriakides has written to...
At a special meeting of European heads of government, to discuss the rise of infection rates across Europe and the emergence of new, more contagious variants,...
The COVID-19 pandemic has changed the world drastically. On the one hand, the immediate targets of reducing the sky-rocketing rates of infection, increasing the capacity of...
Nexelis acquires the GSK vaccines clinical bioanalytical laboratory located in Marburg – Germany and enters into a 5-year strategic agreement with GSK. Laval, Quebec, and Marburg,...